DermaXon is a Montana-based drug discovery company founded in 2013 providing first in-class drug candidates. DermaXon targets the brain-skin connection to discover and develop novel therapeutic strategies to treat life-threatening diseases and disorders such as pain, pruritus and genetic disorders of skin keratinization.

Headquarters: 6610 Justin Ct, Missoula, MT 59803

Laboratories: 32 Campus Drive, Missoula, MT 59812